产品封面图

ANGPT1抗体(C末端)|ANGPT1 Antibody

(CT) (ANGPT1; KIAA0003; Angiopoietin-1)
收藏
  • 询价
  • 艾美捷BioVision
  • 美国
  • 6760-100
  • 2025年06月29日
    avatar
    13皇冠会员
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 技术资料
    • 克隆性

      多克隆

    • 抗体英文名

      ANGPT1 Antibody (CT) (ANGPT1; KIAA0003; Angiopoietin-1)

    • 规格

      100 ul

    产品名称:ANGPT1抗体(C末端)|ANGPT1 Antibody (CT) (ANGPT1; KIAA0003; Angiopoietin-1)

    【产品形式】:艾美捷为您提供的ANGPT1抗体(C末端)产品为无色溶液形式,含有100 ul抗体.该产品浓度为与批次相关,溶解于包含有0.09% (W/V) NaN3的PBS缓冲液中.请在收到该ANGPT1抗体(C末端)产品后,将其置于-20 °C冷冻保存,建议分装使用以避免反复冻融.

    【背景资料】:Angiopoietin-1 (Ang-1) is a secreted ligand for Tie-2, a tyrosine-kinase receptor expressed primarily on vascular endothelial cells and early hematopoietic cells. Ang-1/ Tie-2 signaling promotes angiogenesis during the development, remodeling, and repair of the vascular system. Transgenic mice lacking expression of either Ang-1 or Tie-2 fail to develop a fully functional cardiovascular system and die before birth. Postnatally, the angiogenic activity of Ang-1/Tie-2 is required during normal tissue repair and remodeling of the female endometrium in the menstrual cycle. Ang-1/Tie-2 signaling appears to be regulated by Angiopoietin-2 (Ang-2), a natural antagonist for Tie-2 that exerts its effects through an internal autocrine loop mechanism. In addition to suppressing endothelial cell activation by inhibiting the expression of adhesion and inflammatory molecules, Ang-1 enhances endothelial cell survival and capillary morphogenesis, and lessens capillary permeability. As such, Ang-1 has a potential to become an effective therapeutic agent for treating various endothelium disorders, including several severe human pulmonary diseases. The efficacy of cell-based Ang-1 gene therapy for acute lung injury (ALI) has recently been studied in a rat model of ALI. The results of this study show that such therapy can markedly improve lung condition and suggest that Ang-1 therapy may represent a potential new strategy for the treatment and/or prevention of acute respiratory distress injury (ARDI), a significant cause of morbidity and mortality in critically ill patients. Recombinant human ANG-1, derived from HeLa cells, is a C-terminal histidine tagged glycoprotein which migrates with an apparent molecular mass of 60.0 – 70.0 kDa by SDS-PAGE under reducing conditions. Sequencing analysis shows N-terminal sequences starting with Ser-20 and with Asp-70 of the 498 amino acid precursor protein.

    Biovision

    BioVision的公司总部在美丽的旧金山湾地区,它是全球生命科学公司的领导者.BioVision在开发和研究细胞凋亡检测分析、代谢检测方面具有 卓越的影响力.包括检测各种检测分析试剂盒、相关特色抗体、重组蛋白及细胞因子和酶等多种产品,以及其他创新的研究工具.其产品覆盖细胞凋亡研究、能量代 谢、细胞/组织蛋白提取、氧化应激与损伤、代谢与肥胖症、细胞增殖与毒性、信号转导、干细胞研究等领域.作为多家知名品牌的中国总代理以及中国区域代理, 艾美捷与BioVision一起为研究者们提供最好、最新的细胞生物学研究工具而不断扩大产品及服务质量.

    点击:ANGPT1抗体(C末端),查看更详细产品说明,更多应用、储存、价格、货期等信息请致电400-6800-868垂询BioVision中国区域授权总代理艾美捷科技有限公司。

    Biovision中国总代理艾美捷科技

    关键词:ANGPT1,ANGPT1抗体(C末端)

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    询价
    维百奥(北京)生物科技有限公司
    2025年07月13日询价
    ¥4980.18
    安诺伦(北京)生物科技有限公司
    2025年05月23日询价
    ¥1140
    武汉菲恩生物科技有限公司
    2026年01月06日询价
    询价
    上海圻明生物科技有限公司
    2025年07月08日询价
    ANGPT1抗体(C末端)|ANGPT1 Antibody (CT) (ANGPT1; KIAA0003; Angiopoietin-1)
    询价